Impact of pregnancy on autograft dilatation and aortic valve function following the Ross procedure

Carvajal, Horacio G.; Lindley, Kathryn J.; Shah, Trupti D; Brar, Anoop K.; Barger, Philip M.; Billadello, Joseph J.; Eghtesady, Pirooz

doi:10.1111/chd.12554

Cited by 5 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Surgical intervention may involve either balloon valvotomy or valve replacement. The choice of valve replacement procedure should be a multidisciplinary decision involving a maternal cardiologist and the wider adult congenital cardiac disease multidisciplinary team 19 . Pregnancy accelerates decline in valve function in women with a tissue bioprothesis, while those with a prosthetic (metal) valve will require anticoagulation throughout 6 …”

Section: Pre‐conception Counsellingmentioning

confidence: 99%

“…The choice of valve replacement procedure should be a multidisciplinary decision involving a maternal cardiologist and the wider adult congenital cardiac disease multidisciplinary team. 19 Pregnancy accelerates decline in valve function in women with a tissue bioprothesis, while those with a prosthetic (metal) valve will require anticoagulation throughout. 6 While aortic root dilatation in pregnancy and the resultant risk of aortic dissection are most considered in the context of Marfan syndrome, this may also occur because of bicuspid aortic valve stenosis.…”

Section: Aortic Stenosismentioning

confidence: 99%

See 1 more Smart Citation

Valvular heart disease in pregnancy

Partridge

Timmons

McKelvey

et al. 2023

The Obstetric & Gynaecologis

View full text Add to dashboard Cite

Key content Pregnancy‐induced changes in haemodynamic physiology can place considerable strain on cardiac function in some women with valvular disease. Regurgitant valve lesions are usually better tolerated in pregnancy than stenotic lesions, although the risk of obstetric complications is increased in both. Pre‐conception counselling is essential for all women with valvular disease. Optimising anticoagulation is a particular challenge in women with mechanical valves. Learning objectives To understand the World Health Organization (WHO) classification of maternal cardiac disease and how this affects counselling regarding decisions around pregnancy for women with valve pathology. To understand how valve disease affects pregnancy and vice versa. To gain insight into the anaesthetic and haematological considerations for managing women with valvular disease. Ethical issues What is the optimum anticoagulation regimen for women with mechanical heart valves in pregnancy that balances both maternal and fetal risks?

show abstract

Section: Pre‐conception Counsellingmentioning

confidence: 99%

Section: Aortic Stenosismentioning

confidence: 99%